STORY AT-A-GLANCE Researchers used computational analyses to evaluate the performance of 10 medications against the Omicron variant, finding that ivermectin outperformed all of them, including nirmatrelvir (Paxlovid) a new drug from Pfizer that has cost taxpayers $5.29 billion and costs $529 per course of treatment Ivermectin lowers the viral load by inhibiting replication, reduces infection … Continue reading New Study Confirms Ivermectin Outperforms Other Options